Patent US3175474A successfully refreshed from Google Patents.
US4150128A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method of treating atrophic vulvar dystrophy
Assignee: Individual
•
Filing: 1977-10-25
•
Granted: 1979-04-17
•
Expires: 1997-10-25
Abstract
Abstract The method of treating vulvar dystrophy by topically administering a progestin to the afflicted area. The preferred pharmaceutical formulation for use in the treatment consists of a hydrophilic base containing a suspension of progesterone in oil.
Inventors
- 👤 Edward A. Jasionowski
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-29 20:14
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/56; A61K31/57
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
85 words
A method of treating atrophic vulvar dystrophy in a patient afflicted with an atrophic vulvar dystrophy characterized by contracture of the vulvar skin which comprises topically applying to the afflicted area at least once a day an effective amount for treating said vulvar dystrophy of a pharmaceutical formulation consisting essentially of a pharmaceutically acceptable hydrophilic carrier containing from about 0.1% to about 5% by weight of progesterone dissolved in oil, and continuing said daily application until the symptoms accompanying said vulvar dystrophy have been alleviated.
Claim 2
Independent Claim
85 words
A method of treating atrophic vulvar dystrophy in a patient afflicted with an atrophic vulvar dystrophy characterized by contracture of the vulvar skin which comprises topically applying to the afflicted area at least once a day an effective amount for treating said vulvar dystrophy of a pharmaceutical formulation consisting essentially of a pharmaceutically acceptable hydrophilic carrier containing from about 0.1% to about 5% by weight of progesterone dissolved in oil, and continuing said daily application until the symptoms accompanying said vulvar dystrophy have been alleviated.
Claim 3
Dependent Claim
12 words
The method of claim 1 wherein said vulvar dystrophy is kraurosis vulvae.
Claim 4
Dependent Claim
12 words
The method of claim 1 wherein said vulvar dystrophy is lichen sclerosis.
Claim 5
Dependent Claim
23 words
The method of claim 1 wherein said progesterone is dissolved in a vegetable oil and said vegetable oil is dispersed in said carrier.
Claim 6
Dependent Claim
22 words
The method of claim 4 wherein said pharmaceutically acceptable carrier comprises stearyl alcohol, containing a suspension of white petrolatum and propylene glycol.
Claim 7
Dependent Claim
12 words
The method of claim 4 wherein said pharmaceutical formulation includes an antibiotic.
Claim 8
Dependent Claim
12 words
The method of claim 1 wherein said pharmaceutically acceptable carrier is petrolatum.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1982-04-16 | 1982-10-16 | 1983-04-17 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1986-04-16 | 1986-10-16 | 1987-04-17 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1990-04-16 | 1990-10-16 | 1991-04-17 | $7700.00 | Window Closed / Lapsed |